Mianserin
Overview of the antidepressant drug Mianserin
Mianserin is a tetracyclic antidepressant (TeCA) that is primarily used in the treatment of major depressive disorder. It was first introduced in the 1970s and is known for its unique pharmacological profile, which includes antagonism of various neurotransmitter receptors.
Pharmacology[edit | edit source]
Mianserin acts as an antagonist at several receptor sites, including the histamine H1 receptor, alpha-2 adrenergic receptor, and various serotonin receptors. This receptor antagonism contributes to its antidepressant effects. Unlike many other antidepressants, mianserin does not inhibit the reuptake of serotonin or norepinephrine, which distinguishes it from other classes such as selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs).
Mechanism of Action[edit | edit source]
Mianserin's antidepressant effects are thought to be primarily due to its antagonism of presynaptic alpha-2 adrenergic receptors, which leads to increased release of norepinephrine and serotonin. Additionally, its antagonism of serotonin receptors, particularly the 5-HT2A and 5-HT2C subtypes, may contribute to its mood-enhancing properties.
Clinical Use[edit | edit source]
Mianserin is used in the treatment of major depressive disorder, particularly in patients who may not respond well to other antidepressants. It is sometimes preferred in patients who experience significant side effects from SSRIs or TCAs, as it tends to have a different side effect profile.
Side Effects[edit | edit source]
Common side effects of mianserin include sedation, weight gain, and dizziness. The sedative effects are primarily due to its potent antagonism of the histamine H1 receptor. Mianserin is also associated with a risk of agranulocytosis, a potentially serious condition involving a decrease in white blood cells, which necessitates regular blood monitoring in some patients.
Chemistry[edit | edit source]
Mianserin is a tetracyclic compound, meaning it has four interconnected rings in its chemical structure. This structure is similar to that of other tetracyclic antidepressants, but distinct from the tricyclic structure of TCAs.
Related Compounds[edit | edit source]
Mianserin is closely related to mirtazapine, another tetracyclic antidepressant that shares a similar mechanism of action. Mirtazapine is often used as an alternative to mianserin, particularly in the United States where mianserin is not available.
History[edit | edit source]
Mianserin was developed in the 1970s and was one of the first antidepressants to be marketed as a tetracyclic compound. It was initially introduced in Europe and has since been used in various countries around the world.
Related Pages[edit | edit source]
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD